Alex Oppenheim Omaha
Alex Oppenheim Omaha is a graduate of the University of Nebraska-Lincoln.
Omaha United States
About Me
Alex Oppenheim Omaha is a graduate of the University of Nebraska-Lincoln. From that institution, he holds a degree in biological sciences. In addition to that, Alex Oppenheim Omaha also completed a project work in agricultural biotechnology. During his studies, Alex was able to further develop his scientific skills and knowledge, and get trained by some of the leading experts in the field of biological and agricultural biotechnology sciences. Dedicated to excel in his chosen career, Alex Oppenheim Omaha has completed a series of courses, including his project work in agricultural biotechnology, learning the latest state-of-the-art techniques and approaches for solving biology problems and being thought how to think in a sophisticated way about real-world problems.
Interested in solutions for:
For my portfolioI am looking for healthcare innovations:
You have not backed any projects.
Lets change that!
Discover Projects
No project created yet.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No likes on any project yet..
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No project reviewed yet.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.